GYNECOLOGICAL MALIGNANCIES
Clinical trials for GYNECOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new GYNECOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for GYNECOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for women with hard-to-treat gynecologic cancers?
Disease control Recruiting nowThis study tests an experimental drug called BL-M07D1 in women with recurrent or metastatic gynecologic cancers that have a specific marker called HER2. The goal is to find the best dose and see if the drug can shrink tumors. About 138 participants will receive the drug, and rese…
Matched conditions: GYNECOLOGICAL MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
Blood test could predict immunotherapy success in Women's cancers
Knowledge-focused Recruiting nowThis study looks at whether changes in a blood marker called CRP can help predict how well immunotherapy works in women with advanced gynecological cancers (cervical, endometrial, ovarian, or vulvar). Researchers will follow 120 women receiving immunotherapy plus chemotherapy and…
Matched conditions: GYNECOLOGICAL MALIGNANCIES
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated May 17, 2026 00:51 UTC